The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMS.L Regulatory News (RMS)

  • There is currently no data for RMS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Pharm to Farm Ltd

4 Mar 2021 07:00

RNS Number : 1015R
Remote Monitored Systems PLC
04 March 2021
 

4 March 2021

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Remote Monitored Systems plc

("RMS" or the "Company")

Update on Pharm to Farm Ltd ("P2F")

The Company is pleased to report the significant progress achieved since the announcement on 18 February. 

· Order for 1.0 million of P2F's masks placed with Volz with outsourcing manufacturing discussions in progress

· Distribution agreement to make masks available in UK & Europe via Amazon

· Launch of web site for the P2F mask

· Independent adviser and line manager appointed to bring mask machine into full operation

Further to previous announcements in relation to discussions the Company has held with the Volz Group of Companies ("Volz"), an initial order has been placed for one million of P2F's masks, incorporating P2F's proprietary antiviral material (α-virion), and discussions are under way to extend this into a production outsourcing arrangement to increase the supply of the anti-viral masks. Not only should this approach enable the expected demand for the mask to be met but it will also allow P2F to focus on its core strengths of developing and producing nanomaterials and associated innovative products.

Whilst interest in the masks has been strong, it was important to ensure that potential supply issues had been resolved before committing to deliveries. On the back of the discussions with Volz, P2F has entered into a distribution agreement with Francis McIntyre Limited, an online garment retailer with the brand FM London, ("Francis McIntyre") to make P2F's masks available to customers across the UK and Europe via the Amazon E-commerce platform ("Amazon"). Under the terms of the agreement, Francis McIntyre has placed an initial order for 100,000 masks, with the exclusive right to sell via Amazon being conditional upon Francis McIntyre ordering a minimum of 1 million masks per month. P2F has also started supplying batches of between 5,000 and 10,000 masks to a number of customers looking to trial the product ahead of potentially placing larger orders in the future. A dedicated website for the mask has been created (www.pro-larva.com) and is expected to go live by the end of this week, which should help drive further demand.

P2F is in discussions with Lemu Group, the manufacturer of the mask making machine, regarding mechanical issues that need to be resolved before the machine at BioCity can be considered to be fully commissioned. The Company has agreed to appoint Egremont Capital Limited ("Egremont") as an independent advisor for the next three months to assist with development of P2F's production capabilities. Jonathan Hall, Egremont's founder, has a background in production manufacturing, in addition to Egremont's expertise as a corporate advisor. In addition to a monthly fee, Egremont may be issued with up to 500,000 new ordinary shares dependent on achieving certain production milestones. In addition, a line manager has been recruited at BioCity to strengthen the production team. 

Antony Legge, Executive Chairman of RMS, said; "We are very pleased to update the market with the positive developments achieved by the P2F team. Whilst a number of issues remain with the machine at BioCity, the purchase order with Volz coupled with the intentions by both parties to enter into a more formal outsourced manufacturing agreement, means P2F can commence sales with confidence as we anticipate a continuing market need for P2F's proprietary α-virion material, notwithstanding the progress of various national Covid-19 vaccination programmes."

 

- ENDS -

 

ENQUIRIES:

Remote Monitored Systems plc

Antony Legge (Executive Chairman) via IFC Advisory

 

SP Angel Corporate Finance LLP +44 20 3470 0470

Nominated Adviser and Joint Broker

Stuart Gledhill

Caroline Rowe

 

Peterhouse Capital Limited +44 20 7469 0930

Joint Broker

Lucy Williams

 

IFC Advisory Ltd +44 20 3934 6630

Graham Herring

Zach Cohen

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAEDDEDFFEAA
Date   Source Headline
31st Jan 20177:00 amRNSTotal Voting Rights
25th Jan 20179:00 amRNSNotice of GM
24th Jan 20177:00 amRNSIssue of Equity
23rd Jan 20174:45 pmRNSHolding(s) in Company
20th Jan 20174:50 pmRNSHolding(s) in Company
19th Jan 201711:00 amRNSHolding(s) in Company
22nd Dec 20165:53 pmRNSResult of General Meeting
22nd Dec 20163:36 pmRNSREPLACEMENT: Holdings in Company
22nd Dec 201610:35 amRNSHoldings in Company
1st Dec 20161:00 pmRNSHolding(s) in Company
30th Nov 20167:00 amRNSTotal Voting Rights
28th Nov 20165:02 pmRNSNotice of GM
24th Nov 20168:15 amRNSCorporate Update
30th Sep 20167:00 amRNSHalf-year Report
29th Sep 20169:15 amRNSSettlement of Litigation
8th Sep 20167:00 amRNSWins UK Environment Agency Contract Worth £2.5M
31st Aug 20164:06 pmRNSTotal Voting Rights
25th Aug 20162:30 pmRNSIssue of Equity and Trading Update
24th Aug 201612:16 pmRNSAgreement to Roll-Out UAV Training in Malaysia
23rd Aug 20161:30 pmRNSCivil Aviation Authority Grants NQE Status
11th Aug 20161:00 pmRNSResult of General Meeting
5th Aug 20162:45 pmRNSMedia Reports
29th Jul 20163:16 pmRNSTotal Voting Rights
15th Jul 201610:00 amRNSNotice of General Meeting
13th Jul 20164:00 pmRNSCompletes Acquisition of UK-based Geocurve
13th Jul 20163:30 pmRNSUpdate on Completion of Acquisition of Geocurve
7th Jul 20163:00 pmRNSBoard Changes
30th Jun 20162:30 pmRNSFinal Results
30th Jun 20162:00 pmRNSResult of AGM
30th Jun 20167:00 amRNSAGM Statement
6th Jun 201610:00 amRNSNotice of AGM
12th May 20162:30 pmRNSResult of General Meeting
29th Apr 20162:26 pmRNSTotal Voting Rights
20th Apr 20169:31 amRNSIssue of Equity & Notice of General Meeting
15th Apr 201612:07 pmRNSUpdate Regarding Litigation
6th Apr 20167:00 amRNSResponse to Press Speculation
1st Apr 20164:00 pmRNSCorporate Update and Board Changes
31st Mar 20165:41 pmRNSTotal Voting Rights
17th Mar 201612:15 pmRNSPartial Conversion of Promissory Note
1st Mar 20167:00 amRNSSecures US$375,000 Proprietary Software Contract
19th Feb 20167:00 amRNSSecures First UAV Wind Turbine Inspection Contract
15th Feb 20167:00 amRNSDirectors Dealings
11th Feb 20169:00 amRNSTrading Update
28th Jan 20167:00 amRNSEnters Rapidly Growing Chinese UAV Market
11th Jan 20164:35 pmRNSPrice Monitoring Extension
4th Jan 20162:30 pmRNSTotal Voting Rights
22nd Dec 20157:00 amRNSExercise of Warrants and Issue of Equity
15th Dec 201512:50 pmRNSPresenting at the Unmanned Systems Institute 2015
15th Dec 20158:58 amRNSDirector's Participation in the Placing
11th Dec 20157:00 amRNSAcquisition of Leading UAV Technology Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.